Načítá se...
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
Chimeric antigen receptor (CAR)-modified T cells and bispecific T cell–engaging antibodies have demonstrated dramatic clinical responses in recent clinical trials. The hallmark of these novel highly active immunotherapies is nonphysiologic T cell activation, which has correlated not only with greatl...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4119809/ https://ncbi.nlm.nih.gov/pubmed/24667956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000035 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|